Advanced search
Publication Cover
Cutaneous and Ocular Toxicology Volume 35, 2016 - Issue 3
Submit an article Journal homepage
111
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Isolated sixth nerve palsy after intravitreal ranibizumab injection

Cagatay CaglarDepartment of Ophthalmology, Faculty of Medicine, Hitit University, Corum, TurkeyCorrespondence[email protected]
,
Sücattin Ilker KocamisDepartment of Ophthalmology, Faculty of Medicine, Hitit University, Corum, Turkey
&
Mustafa DurmusDepartment of Ophthalmology, Faculty of Medicine, Hitit University, Corum, Turkey
Pages 248-250 | Received 27 Jun 2015, Accepted 20 Jul 2015, Published online: 24 Aug 2015

References

  • Bakri SJ, Snyder MR, Reid JM, et al. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology 2007;114:2179–2182
  • Carneiro AM, Costa R, Falcao MS, et al. Vascular endothelial growth factor plasma levels before and after treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumab. Acta Ophthalmol 2012;90:25–30
  • Cackett P, Cheung N, Wong TY. Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol 2008;92:1564
  • Johnson D, Sharma S. Ocular and systemic safety of bevacizumab and ranibizumab in patients with neovascular age-related macular degeneration. Curr Opin Ophthalmol 2013;24:205–212
  • Park HJ, Guy J. Sixth nerve palsy post intravitreal bevacizumab for AMD: a new possibly causal relationship and complication? Binocul Vis Strabismus Q 2007;22:209
  • Cakmak HB, Toklu Y, Yorgun MA, Simsek S. Isolated sixth nerve palsy after intravitreal bevacizumab injection. Strabismus 2010;18:18–20
  • Micieli JA, Santiago P, Brent MH. Third nerve palsy following intravitreal anti-VEGF therapy for bilateral neovascular age-related macular degeneration. Acta Ophthalmol 2011;89:99–100
  • Papadopoulou DN, Mendrinos E, Mangioris G, et al. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration. Ophthalmology 2009;116:1755–1761

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.